Spurned by FDA a decade ago, Kyowa Kirin wins nod for Parkinson's drug

28th August 2019 Uncategorised 0

A 10-year wait obviously didn’t discourage Kyowa Kirin from changing the FDA’s mind for its add-on Parkinson’s therapy. Rejected by the FDA in 2008, the pharma’s Nourianz has finally secured a U.S. go-ahead, six years after it was launched in Japan.

More: Spurned by FDA a decade ago, Kyowa Kirin wins nod for Parkinson's drug
Source: fierce